Stock Price
54.27
Daily Change
-1.88 -3.35%
Monthly
19.59%
Yearly
-58.61%
Q3 Forecast
54.42

Novo Nordisk reported DKK42.22B in EBIT for its fiscal quarter ending in March of 2025.


Ebit Change Date
ANI Pharmaceuticals USD 15.17M 10.3M Jun/2025
Aurora Cannabis CAD -17609000 54.46M Jun/2025
Bausch Health Companies USD 605M 18M Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Canopy Growth CAD -31497000 7.68M Jun/2025
Corcept Therapeutics USD 26.67M 23.26M Jun/2025
Drreddys Laboratories INR 19.88B 1.86B Jun/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
GlaxoSmithKline GBP 2.07B 462M Jun/2025
Merck USD 6.36B 149M Jun/2025
Novartis USD -9190000000 13.87B Jun/2025
Novo Nordisk 34.08B 4.71B Jun/2025
Novo Nordisk DKK 42.22B 8.39B Mar/2025
Pacira USD 10.23M 2.21M Jun/2025
Perrigo USD 55.6M 91M Jun/2025
Prestige Brands USD 71.76M 29.14M Jun/2025
Sanofi EUR 1.51B 1.39B Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025
Zoetis USD 1.02B 106M Jun/2025